Patients with atrial fibrillation are at increased risk for medication errors  by Blum, Michael S. & Krumholz, Harlan M.
460A ABSTRACTS - Special Topics 
RR for SCD by Time Period 
1970-1979 1980-1989 1990-1999 
Overall 0.85 (0.65,1.1) 0.60 (0.46,0.79) 0.48 (0.35,0.66) 
No CHD/CHF 0.98 (0.67,1.4) 0.60 (0.40,0.91) 0.53 (0.33,0.85) 
CHD/CHF 0.69 (0.48,0.98) 0.55 (0.38,0.79) 0.40 (0.26,0.61) 
4:15 p.m. 
877-2 Health Resource Util ization in Patients With Life- 
Threatening Ventrlcular Arrhythmla: Results From 
Primary Defibri l lator Implant Study (PRIDE) 
Zefeno Zhana. Angel R. Leon, Steven D. Culler, Andrzej Kosinski, Paige Smith, 
Elizabeth M. Mahoney, William S. Weintreub, Emory Universi~ Atlanta, Georgia. 
Background: The PRIDE trial compared a strategy of immediate cardioverter-defibdllator 
(ICD) implant o a strategy of electrophysiology (EPS) guided therapy in patients with life 
threatening arrhythmias. 208 patients were randomized between 6/96 and 4/99. We 
present a comparison of health care resource utilized dudng the initial hospitalization and 
the 2-year follow-up period. 
Methods: We examined length of stay (LOS) for the initial hospitalization (IH) and rehos- 
pitalizations, the number of emergency room (ER) visits, physician visits and procedural 
tests, the number of days in which anti-an'hythmics and beta-blocker medications were 
used, and the percent of patients utiimataly receiving ICD in each group. 
Results: Age was 65.-11 yrs, 79% male, 61% prior MI, EF 30±15, 50% ventdcular tachy- 
cardia, 35% ventdcular fibdllation, 15% dilated cardiomyopathy, The mean LOS for IH 
was 6.52±5.99 days; 1.19±1.56 days for rehospitalizations. Patients randomized to the 
EPS guided treatment did not consume significantly fewer health care service than 
patients randomized to the primary ICD implant arm during either the initial hospitaliza- 
tion or the 2-year follow-up period. In addition, there was no significant difference 
between the two study arms in the propodion of patients who ultimately received an ICD 
during the study period. Conclusion: There is little difference in health care resources 
accordinQ to initial treatment streta~p/amonQ patients with life threatenlnQ arrh~hmias. 
Primary ICD EPS Guided P value 
(n=105) (n=103) 
LOS for I H (days) 5.9±5.3 7.1 ±6.6 0.12 
LOS for rehospitalization (days) 1.3±1.5 1. I±1.6 0.36 
ER visits(#) 0.5±1.1 0.5±1.0 0.70 
Physician visits(#) 8.2±8.3 8.2±9.9 0.66 
Procedural tests(#) 5.3±9.2 5.6±15.1 0.41 
Anti-arrhythmics(days) 190.2±278.2 174.1¢269.1 0.75 
Beta-Blockers(days) 224.1±303.1 208.0±297.7 0.70 
% receiving ICD 93.3 88.4 0.40 
4:30 p.m. 
877-3 Left Ventricular Diastolic Dysfunction: An Important 
Predictor of Flret Diagnoead Nonvalvular Atrial 
Fibrillation In 840 Elderly Men and Women 
Teresa S. Tseng, Bernard J. Gersh, Chdstopher P. Appleton, Marion E. Barnes, Kent R. 
Bailev, Samantha C. Montgomery, Yasuhiko Takemoto, James B. Seward, Mayo Clinic, 
Rochester, Minnesota. 
Background: Few data exist regarding the relationship between diastolic function and 
nonvalvular atrial fibrillation (NVAF). 
Methods: The clinical and echocardiographic characteristics of a random sample of res- 
idents of Olmeted County, MN, aged > 65 years, who had an echocardiogram performed 
at Mayo Clinic, Olmsted Medical Center, or their affiliated hospitals between 1990 and 
1998 were reviewed. Exclusion cfiteda included history of atrial arrhythmia, stroke, valvu- 
lar or congenital heart disease, or pacemaker implantation. A simple diastolic function 
profile was determined from mitral inflow characteristics and offiine left atrial volume. 
Patients were followed in their medical records to the last clinical visit or death for docu- 
mentation of first atrial fibrillation. 
Reeulte: Of 840 patients (39% men; mean [+ SD] age, 75 + 7 years), 60 (9.5%) devel- 
aped NVAF over a mean (± SD) follow-up of 4.1 ± 2.7 years. Abnormal relaxation, pseud- 
onormal, and restrictive diastolic filling were associated with hazard ratios of 3.33 (95% 
confidence interval [CI], 1.5-7.4; P = 0.003), 4.84 (95% CI, 2,05-11.4; P < 0.001), and 
5.26 (95% CI, 2.3-12.03; P < 0.001), respectively, when compared to normal diastolic 
function. After multiple adjustments, diastolic function profile remained incremental to 
history of congestive heart failure and previous myocardial infarction for prediction of 
NVAF. Age-adjusted Kaplan-Meier 5-year risks of NVAF were 1, 12, 14, and 21 percent 
for normal, abnormal relaxation, pseudonormal, and restrictive diastolic filling, respec- 
tively. 
Conoluelons: The presence and sevedty of diastolic dysfunction are independently pre- 
dictive of first documented NVAF in the eldedy. 
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877-4 Patients With Atrial Fibri l lation Are at Increased Risk for 
Medication Errors 
Michael S. Blum, Harlan M. Krumholz, Yale University School of Medicine, New Haven, 
Connecticut, Yale-New Haven Hospital, New Haven, Connecticut. 
Background: The prevention of medication errors is a national pdodty, but little informa- 
tion is available regarding the frequency of potential medication interactions in hospital- 
ized patients with cardiovascular disease. 
Methods: In support of our medication error reduction program at Yale-New Haven Hos- 
pital (YNHH), we created an Oracle based clinical data repository that works in concert 
with our Eclipsys 7000 clinical information system. This system acts as a safety net for 
the pharmacy staff, alerting them to potential medication errors due to drug-drug and 
drug-allergy interactions. We reviewed this database for the frequency of potential drug 
interactions prescribed at YNHH. 
Results: In June and July 2001, the system screened 162,794 new medication orders, 
Of these, 2402 orders (1.7%) created a potential medical error through a known, impor- 
tant drug-drug interaction. A total of 979 interactions (0.6%) either involved combinations 
in which one or both drugs could have been replaced with a therapeutic equivalent or 
required closer monitoring. Of these 979 potential ADEs, 760 (78%) involved an order for 
warfarin. Moreover, the most common interaction (310 orders, 32%) involved the combi- 
nation of amiodarone and warfarin. Other common combinations that could lead to ADEs 
involved warfadn and non-steroidal anti-inflammatory drags (205 orders, 21%), and war- 
farin and anti-fungal agents (135 orders, 14%). Of the 76 individual patients (1% of hospi- 
tal admissions) prescribed the combination of warfarin and amiodarone, 47% had an INR 
>3.9 duriog the treatment period and 17% had an INR >6. 
Conclusions: Potential interactions with warfadn occurred relatively commonly over the 
two month pedod, with warfarin and amiodarone frequently administered concurrently, 
often leading to over-anticoagulation, The improved use (or avoidance) of this particular 
combination appears to be an opportunity to improve care. 
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890-1 The Kansas City Cardiomyopathy QueaUonnalre Is 
Sensitive to Clinical Change In Congestive Heart Failure 
John A. Soertus. Mark W. Canard, Joseph Rinaldi, Ross Tsuyuki, Harlan Krumholz, 
Ileana Pina, Edward Havranek, Joseph F, Tooley, Cardiovascular Outcomes Research 
Consortium (CORC), Mid America Heart Institute/UMKC, Kansas Ci~ Missouri. 
Background: Health status (symptoms, functional status, and quality of life) is an impor- 
tant health care outcome. The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a 
valid measure of health status in patients with CHR Additional research is needed to 
define the clinical significance of changes in KCCQ scores, The Cardiovascular Out- 
comes Reseamh Consortium (CORC) is a 13-center consortium that is currently con- 
ductiog a study to determine the minimal clinically important change in KCCQ scores. 
Methods: Five hundred outpatients with LVEF<--0.40 will be given the KCCQ at 2 times 
separated by 6±2 weeks. In addition, assessments by both the patient and their physi- 
cian of changes in the patients' condition over this time period will be independently 
ascertained. Comparisons of change in KCCQ scores, 6 minute walk distance and NYHA 
functional class will be made against the gold standard of patients' assessments of 
change. Currently 227 patients have baseline data available and 109 have completed fol- 
low-up. 
Results: Of the 109 patients with complete follow-up, 21 (19.3%) deteriorated, 67 
(61.5%) remained stable and 21 (19.3%) reported improvement. The table 
(*=p<O.05)compares the KCCQ Overall Summary Score with the 6-minute walk test and 
NYHA classification. 
Conclusion: These preliminary data demonstrate that the KCCQ is at least as sensitive 
as traditional measures of patient function. Final data provide finer gradations of changes 
in KCCQ scores. 
Pts reporting Stable Pts Pts reporting Responsiveness 
detedoretion improvement Statistic 
KCCQ change -7.9±12" 2.3±10 8.0±16" 0.79 
6 MWT change -112±168" 20.7±205 90.4±275 0.49 
NYHA change 0.0±0.3 -0.2±.5" -0.05±0.6 0.12 
